Press Release

M&A Advisor Selects Haynes Boone for Deals of Year Awards

June 01, 2022

Two Haynes and Boone, LLP deal teams will receive deal of the year awards from The M&A Advisor at the 13th-Annual International M&A Awards gala on Sept. 21 in New York.

An independent judging panel of industry experts evaluated nominations representing over 250 individual companies from across the world – a wide and varied group with deals valued at $10 million to tens of billions, the M&A Advisor said.

“Since the introduction of the International M&A Awards in 2009, we have continued to witness the dynamic growth of cross border M&A. Geopolitics and technological innovation have played an important role in international dealmaking during this past two years and the winning award nominations certainly reflect that trend,” says Roger Aguinaldo, founder and CEO of The M&A Advisor.

Haynes Boone was recognized for the following deals:

Strides Pharma Science (Cross-Border Deal of the Year: $10 million - $25 million)

A Haynes Boone team led by Partners Simin Sun and Jeff Wolfson represented Strides Pharma Science Limited in a $24 million acquisition announced Aug. 6, 2021. Strides’ wholly owned subsidiaries entered into definitive agreements with subsidiaries of Endo International to acquire its manufacturing facility in New York and various Abbreviated New Drug Applications (ANDAs).

The deal team also included Partner Greg Kramer and Associates Reem Abdelrazik and Maseo Brown. Additional counsel was provided by an interdisciplinary Haynes Boone team, including: Raquel AlvarengaScott ThompsonLucy HongMordechai SuttonJack TuranoSuzie TriggTony SubketkaewJeff CivinsRandall ColsonEd LebowMatt Deffebach and Jennifer Kreick.

Eastern Business Forms (M&A Deal of the Year: $25 million - $50 million; and Private Equity Deal of the Year: $10 million - $100 million)

Generational Equity, a leading mergers and acquisitions advisor for privately held businesses, sold its client, Eastern Business Forms, Inc. (EBF), to private investment firm Gen Cap America.

A Haynes Boone team led by Partner Blaine Statham and Associate Chase Proctor represented EBF in the transaction. EBF is a privately owned company with more than 50 years of experience manufacturing newborn screening devices. It is the exclusive provider of 903 filter paper worldwide for diagnostic use and has extensive experience in the design and manufacture of 903 diagnostic devices and procedure packs.

Generational Equity Managing Director Don Ho credited Statham and Proctor for their hard work and dedication to the transaction.

“Their unique skill-sets and practical approach to problem-solving were instrumental given the complexity of this transaction. We were fortunate to work with such great professionals to get another deal closed,” Ho stated in a press release.

Haynes Boone M&A lawyers have comprehensive experience handling middle market deals (including in the pharmaceutical and insurance industries), having helped clients close more than 500 transactions in the last five years, with an aggregate value exceeding $40 billion. The group routinely represents private equity firms, closely held corporations, founders, large financial institutions, and Fortune 500 public companies. Haynes Boone’s M&A Practice Group was ranked among the top firms in Texas (Band 4) by Chambers USA (Chambers and Partners) in 2021.

Haynes and Boone, LLP is an international corporate law firm with 18 offices, spanning Texas, New York, California, Charlotte, Chicago, Denver, Washington, D.C., London, Mexico City and Shanghai, providing a full spectrum of legal services in energy, technology, financial services and private equity. With 600 lawyers, Haynes Boone is ranked among the largest U.S.-based firms by The National Law Journal, The American Lawyer and The Lawyer. It was recognized in the BTI Consulting Group’s 2022 “A-Team” report, which identifies the law firms that in-house counsel commend for providing superior client service.